PharmPass: GPhC Exam Prep
PharmPass is an exam preparation app for GPhC registration assessment candidates, featuring clinical MCQs and timed mock exams on iOS.
The App DNA
What makes this app unique?
It removes the time cost of filtering irrelevant study material, allowing candidates to focus exclusively on the specific clinical categories required for the GPhC assessment.
For Trainee and foundation pharmacists preparing for the GPhC registration assessment.
What does it look like?
Key features
6,000+ questions covering clinical categories; content volume drives the subscription value proposition.
Simulated exam environment; premium-tier gate incentivizes paid conversion.
Dedicated bank with step-by-step solutions; justifies the price point for technical proficiency needs.
How much does it cost?
Subscription model anchored at £60/year, utilizing tiered duration discounts to encourage long-term commitment.
Velocity
Maintenance developmentUX improvementsperformanceShow more...
The app currently operates at a maintenance cadence, with only one release shipped in the last 95 days. Development is focused on minor stability and layout refinements rather than new content or major feature expansion. Given the current pace, the app remains in a state of low-frequency updates. No significant feature additions have been observed in the recent history.
Who built it?
ARBAZ MOHAMMED
2 apps tracked · Education
SERUPass - TFL PCO Exam PrepUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for PharmPass: GPhC Exam Prep
How's the Education market?
PharmPass operates in the niche education segment, currently holding zero public ratings and no chart rank. The lack of social proof relative to the £60 annual price point suggests a high acquisition friction for new users.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for PharmPass: GPhC Exam Prep
Where is it heading?
The pharmacy exam prep market is consolidating around platforms that offer verified, up-to-date clinical content. PharmPass remains exposed due to its lack of recent feature investment and public social proof, which will likely lead to stagnation if the content bank is not actively refreshed for the next exam cycle.
- Maintenance-only release cadence (95 days since update) risks content obsolescence, which erodes the value proposition for high-stakes exam prep.
- The £60 annual price point requires consistent content updates to justify the cost, yet current development velocity remains dormant.
The SWOT
- Clinical MCQ library functions as a distribution barrier for GPhC-specific trainees.
- Timed mock environment replicates high-stakes assessment, creating high switching costs.
- Introduce peer-study features to leverage the cohort-based nature of the GPhC assessment.
- Implement diagnostic dashboards for personalized study paths, increasing question bank utility.
Next best moves
Implement a 'refer-a-friend' study group discount because current lack of social proof hinders acquisition → increase organic install velocity
+ 1 more prioritized moveThe counter-intuitive read
The lack of public ratings is not just a weakness…
Read the full takeBottom line
PharmPass must pivot from maintenance to active content verification to justify its £60 annual price point. Establishing social proof through user-referral loops would address the trust gap currently preventing new user acquisition.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated